Paolo Buonpensiero

Naples, Italy

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 12 publications

The Role of ETI Therapy in Managing Sinusitis in Cystic Fibrosis pediatric population: A Study on Clinical Outcomes.

The Role of ETI Therapy in Managing Sinusitis in Cystic Fibrosis pediatric population: A Study on Clinical Outcomes.

Journal: Respiratory medicine

Published: January 16, 2026

Elexacaftor/Tezacaftor/Ivacaftor Therapy in a Child With Cystic Fibrosis and Type 1 Spinal Muscular Atrophy.

Elexacaftor/Tezacaftor/Ivacaftor Therapy in a Child With Cystic Fibrosis and Type 1 Spinal Muscular Atrophy.

Journal: Pediatric pulmonology

Published: October 07, 2025

Peak nasal inspiratory flow as an adjunct measure of respiratory function in paediatric cystic fibrosis.

Peak nasal inspiratory flow as an adjunct measure of respiratory function in paediatric cystic fibrosis.

Journal: Journal of cystic fibrosis : official journal of the European Cystic Fibrosis Society

Published: June 01, 2025

Efficacy of Elexacaftor/Tezacaftor/Ivacaftor in a Cystic Fibrosis Child With L1077P Mutation.

Efficacy of Elexacaftor/Tezacaftor/Ivacaftor in a Cystic Fibrosis Child With L1077P Mutation.

Journal: Pediatric pulmonology

Published: October 17, 2024

The Role of Bronchoscopy in the Management of Children With Cystic Fibrosis.

The Role of Bronchoscopy in the Management of Children With Cystic Fibrosis.

Journal: Journal of bronchology & interventional pulmonology

Published: July 08, 2021

A complicated association between two different genetic rare disorders: cystic fibrosis and spinal muscular atrophy.

A complicated association between two different genetic rare disorders: cystic fibrosis and spinal muscular atrophy.

Journal: Minerva pediatrics

Published: April 06, 2021

Home physiotherapists assisting follow-up treatment in cystic fibrosis: a multicenter observational study.

Home physiotherapists assisting follow-up treatment in cystic fibrosis: a multicenter observational study.

Journal: Monaldi archives for chest disease = Archivio Monaldi per le malattie del torace

Published: September 23, 2020

Long-term benefits of nusinersen in a child affected by cystic fibrosis and spinal muscular atrophy type 1.

Long-term benefits of nusinersen in a child affected by cystic fibrosis and spinal muscular atrophy type 1.

Journal: Pediatric pulmonology

Published: May 27, 2020

High flow oxygen therapy and the work of breathing assessed by thickening fraction of the diaphragm (TFdi): just a side of the moon in cystic fibrosis patients?

High flow oxygen therapy and the work of breathing assessed by thickening fraction of the diaphragm (TFdi): just a side of the moon in cystic fibrosis patients?

Journal: Annals of translational medicine

Published: March 25, 2019

A novel treatment of cystic fibrosis acting on-target: cysteamine plus epigallocatechin gallate for the autophagy-dependent rescue of class II-mutated CFTR.

A novel treatment of cystic fibrosis acting on-target: cysteamine plus epigallocatechin gallate for the autophagy-dependent rescue of class II-mutated CFTR.

Journal: Cell death and differentiation

Published: July 23, 2016

A novel treatment of cystic fibrosis acting on-target: cysteamine plus epigallocatechin gallate for the autophagy-dependent rescue of class II-mutated CFTR.

A novel treatment of cystic fibrosis acting on-target: cysteamine plus epigallocatechin gallate for the autophagy-dependent rescue of class II-mutated CFTR.

Journal: Cell death and differentiation

Published: November 25, 2015

Randomized, single blind, controlled trial of inhaled glutathione vs placebo in patients with cystic fibrosis.

Randomized, single blind, controlled trial of inhaled glutathione vs placebo in patients with cystic fibrosis.

Journal: Journal of cystic fibrosis : official journal of the European Cystic Fibrosis Society

Published: May 25, 2014

Showing 1-12 of 12

Last Updated: 09/26/2026